Tanaka, Masaru

From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics

Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences

Barrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Cited by 13

Harnessing Dietary Tryptophan: Bridging the Gap Between Neurobiology and Psychiatry in Depression Management

Chehadi, A. C., Pereira de Lima, E., Detregiachi, C. R. P., Santos de Argollo Haber, R., Catharin, V. M. C. S., Fornari Laurindo, L., Engracia Valenti, V., Machado Galhardi, C., Tanaka, M., & Maria Barbalho, S. (2026) · International Journal of Molecular Sciences

Tryptophan and brain disordersTreatment of Major Depression

Cited by 8

Receptor–Mitochondria Crosstalk in the Kynurenine Metabolic Pathway: Integrating Metabolomics and Clinical Mass Spectrometry

Juhász, L., Galla, Z., Tanaka, M., & Vécsei, L. (2026) · Antioxidants

Tryptophan and brain disordersSirtuins and Resveratrol in Medicine

Cited by 5

Identification of a diagnosis-selective neurobiological substrate for bipolar disorder, major depressive disorder, and schizophrenia: A meta-analysis of 57,717 subjects

Liloia, D., Rocca, P., Brasso, C., Tanaka, M., Manuello, J., Crocetta, A., Duca, S., Costa, T., & Cauda, F. (2026) · Psychological Medicine

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 4

Screen, Sample, Stratify: Biomarkers and Machine Learning Compress Dementia Pathways

Battaglia, S., & Tanaka, M. (2026) · Biomedicines

Dementia and Cognitive Impairment ResearchArtificial Intelligence in Healthcare

Cited by 2